Latest Articles

Breast Cancer Breast Cancer Risk Higher in Men Previously Treated for Lymphoma According to Research

Breast Cancer Risk Higher in Men Previously Treated for Lymphoma According to Research

Researchers found that, among men previously treated for lymphoma, the incidence of breast cancer is higher than in the general population.

Skin Cancer Q&A With Keith Flaherty, MD: Dabrafenib and Trametinib for Melanoma

Q&A With Keith Flaherty, MD: Dabrafenib and Trametinib for Melanoma

Cancer Therapy Advisor interviewed Keith Flaherty, MD, about recent findings regarding targeted therapies for melanoma.

Prostate Cancer Prostate Cancer Treatment: Abiraterone and Other Hormonal Therapies Being Studied

Prostate Cancer Treatment: Abiraterone and Other Hormonal Therapies Being Studied

More studies are needed to define the role of intratumoral androgen production and mCRPC resistance to hormonal therapies, and to determine if inhibitors of other steroidogenesis enzymes can be synergistic with abiraterone.

General Oncology Clinicians Advocate for Patients With Sexual Dysfunction After Cancer, A Quality of Life Issue

Clinicians Advocate for Patients With Sexual Dysfunction After Cancer, A Quality of Life Issue

Clinicians are advocating that sexual dysfunction after cancer, which affects a large proportion of survivors, be addressed as a serious quality of life issue.

Skin Cancer Immune Checkpoint Inhibitors: Treatment Efficacy in Elderly Patients With Melanoma

Immune Checkpoint Inhibitors: Treatment Efficacy in Elderly Patients With Melanoma

Immune checkpoint inhibitors may be effective for treating elderly patients with melanoma without dramatically increasing toxicity.

Lung Cancer Lung Cancer Treatment Shows Promise With TG4010 and CIMAvax-EGF Vaccine Therapies

Lung Cancer Treatment Shows Promise With TG4010 and CIMAvax-EGF Vaccine Therapies

Two vaccine therapies, TG4010 and CIMAvax-EGF, show promise for treating lung cancer. Developed and approved for use in Cuba, CIMAvax-EGF is now undergoing clinical study in the United States.

Lymphoma Pembrolizumab May Effectively Treat Mediastinal B Cell Lymphoma

Pembrolizumab May Effectively Treat Mediastinal B Cell Lymphoma

Pembrolizumab may be an effective treatment for patients with a rare subtype of diffuse large B-cell lymphoma, which usually carries a poor prognosis.

Prostate Cancer Liquid Biopsy for Patients With Prostate Cancer May Determine Drug Treatment Response

Liquid Biopsy for Patients With Prostate Cancer May Determine Drug Treatment Response

A recent study suggests that a liquid biopsy may help oncologists to determine which patients with prostate cancer are likely to respond to enzalutamide or abiraterone.

General Oncology Pediatric Cancer Researchers Look To Preserve Reproductive Potential of Survivors

Pediatric Cancer Researchers Look To Preserve Reproductive Potential of Survivors

While survival rates of pediatric patients with cancer are greatly improved, researchers and clinicians are evaluating how to best preserve the reproductive potential of survivors.

Gynecologic Cancer Ovarian/Breast Cancer Vaccine Research Looks To Establish Therapeutic Efficacy

Ovarian/Breast Cancer Vaccine Research Looks To Establish Therapeutic Efficacy

Researchers are developing vaccines for patients with ovarian or breast cancer, with timing and vector being increasingly important factors for establishing therapeutic efficacy.

Lung Cancer Q&A With Matthew Rabinowitz, PhD: Detecting Relapse by Liquid Biopsy

Q&A With Matthew Rabinowitz, PhD: Detecting Relapse by Liquid Biopsy

Cancer Therapy Advisor asked Dr Rabinowitz, founder and CEO of Natera, about the bespoke PCR technology and ongoing studies.

Brain Cancer Glioblastoma Survival Rates May Improve With New Immunotherapeutic Approach

Glioblastoma Survival Rates May Improve With New Immunotherapeutic Approach

New immunotherapeutic approaches, such as dendritic cell vaccination, may be effective for treating this rare brain cancer, which is associated with dismal survival rates.

Multiple Myeloma Multiple Myeloma Drug Resistance: New Immunotherapies May Improve Survival

Multiple Myeloma Drug Resistance: New Immunotherapies May Improve Survival

Increasing genetic complexity over time allows multiple myeloma to acquire drug resistance, but immunotherapies that overcome this hurdle might improve overall survival.

General Oncology Q&A With Scott Roberts, PhD: Direct-to-Consumer Cancer Gene Testing

Q&A With Scott Roberts, PhD: Direct-to-Consumer Cancer Gene Testing

In this question-and-answer session, Cancer Therapy Advisor asked Dr Roberts about direct-to-consumer genomic testing for cancer risk.

Renal Cell Carcinoma Q&A With Nilay Shah, MD: Cabozantinib Treatment in Children With Recurrent Metastatic RCC

Q&A With Nilay Shah, MD: Cabozantinib Treatment in Children With Recurrent Metastatic RCC

Cancer Therapy Advisor interviewed Dr Shah regarding 2 recent case studies about pediatric patients with RCC who responded to cabozantinib.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters